Koyfin Home > Directory > Health Care > Amgen Inc > Long-Term Investments

Amgen Inc Long-Term Investments Chart (AMGN)

Amgen Inc annual/quarterly Long-Term Investments from 2010 to 2020.
  • Amgen Inc Long-Term Investments for the quarter ending June 06, 2020 was $3,791m a 79.79% increase of 3,025m year over year
  • Amgen Inc Long-Term Investments for the last 12 months ending June 06, 2020 was $3,791m a 79.79% increase of 3,025m year over year
  • Amgen Inc Annual Long-Term Investments for 2019 was $799m a 14.52% increase of 116m from 2018
  • Amgen Inc Annual Long-Term Investments for 2018 was $683m a -50.37% decrease of -344m from 2017
  • Amgen Inc Annual Long-Term Investments for 2017 was $1,027m a 20.84% increase of 214m from 2016
Other Cash Flow Metrics:
  • Amgen Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $3,194m a 14.62% increase of 467m year over year
  • Amgen Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $3,068m a 48.86% increase of 1,499m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN Long-Term Investments Data

06/2020$3,791m
03/2020$3,334m
12/2019$799m
09/2019$766m
06/2019$768m
03/2019$706m
12/2018$683m
09/2018$509m
06/2018$466m
03/2018$409m

Annual AMGN Long-Term Investments Data

2019$799m
2018$683m
2017$1,027m
2016$813m
2015$579m
2014$522m
2013$395m
2012$454m
2011$442m
2010$448m